TGFB1 and glaucoma: Oxymatrine (OMT) has been chosen for this study because various researches and a literature review revealed it to be a potent inhibitor of TGFβ, an ECM protein extensively found in the TM and ONH and involved in the fibrotic pathway in glaucoma.